Verapamil protects against progression of experimental chronic renal failure

C.H. David Harris(University of Colorado Denver), William S. Hammond(University of Colorado Denver), Thomas J. Burke(University of Colorado Denver), Robert W. Schrier(University of Colorado Denver)

Kidney International

January 1, 1987

10.1038/ki.1987.6

Cited by 153Open Access

Abstract

Related Papers

Albumin standards and the measurement of serum albumin with bromcresol green

Basil T. Doumas, W. Ard Watson, Homer G. Biggs|Clinica Chimica Acta|1997|2.8k

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.

Sharon Anderson, Helmut G. Rennke, Barry M. Brenner|Journal of Clinical Investigation|1986|1.1k

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.

Sharon Anderson, Timothy W. Meyer, Helmut G. Rennke et al.|Journal of Clinical Investigation|1985|942

Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3.

Karl A. Nath, Margaret K. Hostetter, Thomas H. Hostetter|Journal of Clinical Investigation|1985|493

Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation.

Mabel L. Purkerson, J H Joist, Jesse Yates et al.|Proceedings of the National Academy of Sciences|1985|188